AIBT
AIBOTICS, INC.
Key Financials
Operating Income
$-1844673
↓ 12.8%
Net Income
$-2215751
↓ 19.9%
Revenue
$2183
↑ Infinity%
Gross Profit
$2183
↑ Infinity%
Total Assets
$874673.00
↓ 40.0%
Shareholders' Equity
$-3960232.00
↓ 16.7%
Total Liabilities
$4.8M
↓ 0.3%
Operating Cash Flow
$-458240.00
↓ 76.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 6/9/2026 | View on SEC |
| NT 10-Q | 5/15/2026 | View on SEC |
| 10-K | 4/15/2026 | View on SEC |
| NT 10-K | 3/31/2026 | View on SEC |
| S-8 | 1/28/2026 | View on SEC |
| 10-Q | 11/19/2025 | View on SEC |
| NT 10-Q | 11/14/2025 | View on SEC |
| 10-Q | 8/19/2025 | View on SEC |
| NT 10-Q | 8/14/2025 | View on SEC |
| 4 | 7/28/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | AIBT |
| Company Name | AIBOTICS, INC. |
| CIK | 1763329 |
| Sector | Medicinal Chemicals & Botanical Products |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2833 |
| SIC Description | Medicinal Chemicals & Botanical Products |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NV |
| Phone | 208-677-2020 |